·   Log in

Archive for March, 2010

Dr Reddy’s issues six bonus debentures for every one share

Wednesday, March 31, 2010 21:16

Dr Reddy's Laboratories Ltd, India's second largest drugmaker by sales, would issue bonus debentures worth 5.20 billion rupees ($116 million) to its shareholders, the company announced.

This was posted under category: Featured, Industry  |  Read Full Story  |  0 Comments
Tagged with:

Davunetide increases cognitive functions in schizophrenia: Allon

Wednesday, March 31, 2010 20:49

Davunetide significantly increases neuroprotective biomarker level in schizophrenia patients, Allon Therapeutics Inc studies showed.

This was posted under category: Discoveries  |  Read Full Story  |  0 Comments
Tagged with: ,

Oral pill to treat advanced gastric cancer tesetaxel by Genta is around the corner

Wednesday, March 31, 2010 20:32

Tesetaxel, an oral therapy against advanced gastric cancer, will soon undergo safety studies in humans.

This was posted under category: Biotech  |  Read Full Story  |  0 Comments
Tagged with: , ,

Acetylcysteine (Acetadote) could prevent liver failure: Cumberland

Wednesday, March 31, 2010 20:28

Acetylcysteine can be useful in treating liver failure, results from studies conducted by Cumberland Pharmaceuticals Inc suggest.

This was posted under category: Clinical Trials  |  Read Full Story  |  0 Comments

SciClone’s SCV-07 delays oral mucositis caused by cancer therapy

Wednesday, March 31, 2010 20:27

SCV-07, an experimental drug to treat oral mucositis caused by chemotherapy, has been shown to delay the occurrence of the severe form of the disease.

This was posted under category: health  |  Read Full Story  |  0 Comments
Tagged with:

India’s Indoco in supply pact with Aspen on generic ophthalmic drugs for emerging markets

Wednesday, March 31, 2010 8:04

Indian generic firm Indoco Remedies has entered into a supply arrangement with South Africa's Aspen on ophthalmic products for emerging markets.

This was posted under category: Industry  |  Read Full Story  |  0 Comments

Reolysin shows promise in lung cancer, says Oncolytics

Tuesday, March 30, 2010 21:45

Reolysin, an investigative drug to be used in combination with carboplatin and paclitaxel in patients with lung cancer, will soon undergo phase 2 studies to evaluate its efficacy.

This was posted under category: Discoveries  |  Read Full Story  |  0 Comments
Tagged with: ,

No plan to delist Ranbaxy from Indian bourses: Daiichi

Tuesday, March 30, 2010 21:33

Daiichi Sankyo Co has stated that the Japanese firm has no plans to delist Ranbaxy from Indian bourses denying reports.

This was posted under category: Featured, Industry  |  Read Full Story  |  0 Comments
Tagged with: ,

Parenteral Biotech to market Sinovac’s flu vaccines in India

Tuesday, March 30, 2010 21:19

Parenteral Biotech Ltd., a subsidiary of Parenteral Drugs (India), Ltd will launch Sinovac's seasonal influenza vaccine Anflu and H1N1 vaccine Panflu.1 in India.

This was posted under category: Biotech, Featured  |  Read Full Story  |  0 Comments

Aiko Bio’s constipation drug Aiko-150 completes phase 1 human studies

Tuesday, March 30, 2010 21:14

AIKO-150, an experimental drug to treat to treat constipation associated with opoid use, has completed the second phase-I human clinical, Aiko Bio announced.

This was posted under category: Clinical Trials  |  Read Full Story  |  0 Comments
Tagged with: ,